• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高终末期肝病模型评分患者行活体肝移植术后院内死亡的风险因素。

Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.

机构信息

Division of Liver Transplantation, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Ann Hepatol. 2012 Jul-Aug;11(4):471-7.

PMID:22700628
Abstract

BACKGROUND

Living donor liver transplantation (LDLT) for patients with high model for end-stage liver disease (MELD) scores is controversial due to its poor outcome. However, there is little information regarding which factor would negatively impact the outcome of patients with high MELD scores. The aim of this study was to identify factors associated with the in-hospital mortality of patients with high MELD scores after LDLT.

MATERIAL AND METHODS

All patients with an MELD scores ≥ 20 who received LDLT from 2005 to 2011 were recruited for the present study. Pre- and intra-operative variables were retrospectively and statistically analyzed.

RESULTS

A total of 61 patients were included in the current study. The overall 3-month survival rate was 82% for patients with high MELD scores. Preoperative renal dysfunction, hyponatremia, starting albumin level < 2.8 g/dL, preoperative renal replacement for severe renal failure, anhepatic period > 100 minutes and intraoperative red blood cell (RBC) transfusion ≥ 10 units were identified as potential risk factors by univariate analysis. However, only hyponatremia, preoperative dialysis and massive RBC transfusion were independent risk factors in a multivariate analysis. The 3-month survival rates of patients with two or more independent risk factors and patients with none or one risk factor were 91 and 25%, respectively. A significant difference was observed (P < 0.001).

CONCLUSION

Hyponatremia, preoperative dialysis and massive RBC transfusion were related to poor outcome for sicker patients. Patients with two or more of the above-mentioned risk factors and high MELD scores may exhibit extremely poor short-term survival.

摘要

背景

由于预后较差,对于 MELD 评分较高的患者,活体肝移植(LDLT)存在争议。然而,关于哪些因素会对 MELD 评分较高患者的预后产生负面影响的信息很少。本研究的目的是确定与 LDLT 后 MELD 评分较高患者住院死亡率相关的因素。

材料和方法

本研究纳入了 2005 年至 2011 年接受 LDLT 的所有 MELD 评分≥20 的患者。回顾性和统计学分析了术前和术中变量。

结果

共有 61 例患者纳入本研究。MELD 评分较高患者的 3 个月总体生存率为 82%。单因素分析显示,术前肾功能不全、低钠血症、白蛋白起始水平<2.8 g/dL、术前因严重肾衰竭行肾脏替代治疗、无肝期>100 分钟和术中红细胞(RBC)输注≥10 单位是潜在的危险因素。然而,多因素分析仅显示低钠血症、术前透析和大量 RBC 输注是独立的危险因素。有两个或更多独立危险因素的患者和无或只有一个危险因素的患者的 3 个月生存率分别为 91%和 25%,差异有统计学意义(P<0.001)。

结论

低钠血症、术前透析和大量 RBC 输注与病情较重患者的不良预后相关。MELD 评分较高且具有上述两个或更多危险因素的患者可能会表现出极差的短期生存率。

相似文献

1
Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.高终末期肝病模型评分患者行活体肝移植术后院内死亡的风险因素。
Ann Hepatol. 2012 Jul-Aug;11(4):471-7.
2
Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.终末期肝病模型评分高的患者右半肝活体肝移植的生存结果。
Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):256-62. doi: 10.1016/s1499-3872(13)60042-9.
3
Predictors of patient survival following living donor liver transplantation.活体供肝移植后患者生存的预测因素。
Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):248-53. doi: 10.1016/s1499-3872(11)60041-6.
4
Risk factors for abdominal bleeding after living-donor liver transplant.活体肝移植术后腹腔出血的危险因素。
Exp Clin Transplant. 2014 Oct;12(5):424-8. doi: 10.6002/ect.2013.0223. Epub 2014 Feb 25.
5
Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.终末期胆道疾病肝移植的结局:与终末期肝病的比较研究
World J Gastroenterol. 2015 May 28;21(20):6296-303. doi: 10.3748/wjg.v21.i20.6296.
6
High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.高终末期肝病模型(MELD)评分对活体肝移植受者的预后并无不利影响:1000例受者的经验
Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13006.
7
Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.在乙肝流行地区,对终末期肝病模型评分≥35的患者进行活体供肝与尸体供肝肝移植的短期和长期疗效比较
Ann Surg. 2017 Jan;265(1):173-177. doi: 10.1097/SLA.0000000000001671.
8
Impact of preoperative serum sodium concentration in living donor liver transplantation.术前血清钠浓度对活体肝移植的影响。
J Gastroenterol Hepatol. 2010 May;25(5):978-84. doi: 10.1111/j.1440-1746.2009.06162.x.
9
Living donor liver transplantation with body-weight more or less than 10 kilograms.活体供肝肝移植,供体体重与受体相差10千克左右。
World J Gastroenterol. 2015 Jun 21;21(23):7248-53. doi: 10.3748/wjg.v21.i23.7248.
10
Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.终末期肝病模型评分低的肝移植候选者的结局
Liver Transpl. 2015 Nov;21(11):1403-9. doi: 10.1002/lt.24307.

引用本文的文献

1
Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.丙型肝炎相关肝硬化患者肝移植后肝细胞癌复发和生存的危险因素。
Biomed Res Int. 2020 Oct 17;2020:1487593. doi: 10.1155/2020/1487593. eCollection 2020.
2
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.将胰岛素样生长因子 1 水平纳入终末期肝病模型评分对肝癌患者生存预测的影响。
Oncology. 2020;98(12):836-846. doi: 10.1159/000502482. Epub 2020 Oct 7.
3
Influence of intraoperative oxygen content on early postoperative graft dysfunction in living donor liver transplantation: A STROBE-compliant retrospective observational study.
术中氧含量对活体肝移植术后早期移植物功能障碍的影响:一项符合STROBE标准的回顾性观察研究。
Medicine (Baltimore). 2020 May 22;99(21):e20339. doi: 10.1097/MD.0000000000020339.
4
Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation.围手术期单供体血小板单采术和红细胞输血对活体肝移植 90 天和总生存率的影响。
Chin Med J (Engl). 2018 Feb 20;131(4):426-434. doi: 10.4103/0366-6999.225049.
5
Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis.全身炎症反应综合征的存在预示着原发性肝炎犬的临床预后不良。
PLoS One. 2016 Jan 25;11(1):e0146560. doi: 10.1371/journal.pone.0146560. eCollection 2016.
6
Living Donor Liver Transplant is a Transparent Activity in India.活体肝移植在印度是一项透明的活动。
J Clin Exp Hepatol. 2013 Mar;3(1):61-5. doi: 10.1016/j.jceh.2012.10.001. Epub 2012 Oct 13.
7
Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival.肝移植首次切肝后大量输血可预测肾脏预后及生存情况。
Langenbecks Arch Surg. 2014 Apr;399(4):429-40. doi: 10.1007/s00423-014-1181-y. Epub 2014 Mar 30.
8
Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts.小体积供肝右半肝活体肝移植患者的结局。
World J Gastroenterol. 2014 Jan 7;20(1):282-9. doi: 10.3748/wjg.v20.i1.282.